Tolkachjov Stanislav N, Schmitt Adam R, Muzic John G, Weaver Amy L, Baum Christian L
*Department of Dermatology, Mayo Clinic, Rochester, Minnesota;†Division of Biomedical Statistics and Informatics, Mayo Clinic Rochester, Minnesota;‡Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota.
Dermatol Surg. 2017 Jan;43(1):116-124. doi: 10.1097/DSS.0000000000000936.
The incidence of rare cutaneous malignancies is unknown. Current estimates of rare cutaneous malignancy incidences are based on broad epidemiologic data or single institution experiences, not population-based data.
To determine the incidence of several rare nonmelanoma skin cancers.
The authors conducted a retrospective chart review of a population-based cohort between the years 2000 and 2010. Residents of Olmsted County, Minnesota, who were diagnosed with a biopsy-proven nonmelanoma skin cancer-excluding basal cell carcinoma and squamous cell carcinoma-were included in this study. The primary outcome was tumor incidence. Additionally, the authors extracted patient demographics, tumor characteristics, treatment modalities, and outcomes.
The age-adjusted and sex-adjusted incidences per 100,000 persons of multiple rare cutaneous malignancies were: atypical fibroxanthoma (1.8), sebaceous carcinoma (0.8), dermatofibrosarcoma protuberans (0.4), microcystic adnexal carcinoma (0.7), eccrine carcinoma (0.4), eccrine porocarcinoma (0.2), and leiomyosarcoma (0.2).
The authors report population-based incidences and clinical characteristics for these rare cutaneous malignancies. The immune status and smoking status of patients and the treatment and outcomes of these tumors are reported. Additional studies in a broader population are needed to further define the epidemiology and outcomes of these malignancies.
罕见皮肤恶性肿瘤的发病率尚不清楚。目前对罕见皮肤恶性肿瘤发病率的估计是基于广泛的流行病学数据或单一机构的经验,而非基于人群的数据。
确定几种罕见的非黑色素瘤皮肤癌的发病率。
作者对2000年至2010年期间基于人群的队列进行了回顾性病历审查。明尼苏达州奥尔姆斯特德县被活检证实患有非黑色素瘤皮肤癌(不包括基底细胞癌和鳞状细胞癌)的居民纳入本研究。主要结局是肿瘤发病率。此外,作者提取了患者的人口统计学信息、肿瘤特征、治疗方式和结局。
每10万人中多种罕见皮肤恶性肿瘤的年龄调整和性别调整发病率分别为:非典型纤维黄色瘤(1.8)、皮脂腺癌(0.8)、隆突性皮肤纤维肉瘤(0.4)、微囊性附属器癌(0.7)、汗腺癌(0.4)、汗腺导管癌(0.2)和平滑肌肉瘤(0.2)。
作者报告了这些罕见皮肤恶性肿瘤基于人群的发病率和临床特征。报告了患者的免疫状态和吸烟状态以及这些肿瘤的治疗和结局。需要在更广泛的人群中进行进一步研究,以进一步明确这些恶性肿瘤的流行病学和结局。